Literature DB >> 25075027

Dehydroepiandrosterone inhibits proliferation and suppresses migration of human cervical cancer cell lines.

Yasmín Nansi Ortega-Calderón1, Rebeca López-Marure2.   

Abstract

Dehydroepiandrosterone (DHEA), an adrenal steroid which is most abundant in human plasma, has a protective role against several types of cancer; however, its mechanisms of action are unknown. We evaluated the effect of DHEA on the proliferation and migration of three cell lines derived from cervical cancer. Cell proliferation was evaluated by crystal violet staining; migration by attachment, transwell and wound assays. DHEA inhibited the proliferation of InBl and SiHa cells, with a half-maximal inhibitory concentration (IC50) of 30 μM, whereas the proliferation of HeLa cells was inhibited with an IC50 of 70 μM. DHEA at these IC50 inhibited attachment of cells to the plastic surface of the culture wells, and migration, was evaluated using transwells after 24 h of exposure. DHEA also reduced migration of the three cell lines into the wound area. These results suggest that a possible mechanism of DHEA in protecting against cervical cancer is the inhibition of proliferation and migration of tumor cells. DHEA could be useful in the prevention or treatment of cervical cancer. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Cervical cancer; adhesion; dehydroepiandrosterone; migration; proliferation

Mesh:

Substances:

Year:  2014        PMID: 25075027

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Dehydroepiandrosterone inhibits events related with the metastatic process in breast tumor cell lines.

Authors:  Rebeca López-Marure; Estrella Zapata-Gómez; Leticia Rocha-Zavaleta; María Cecilia Aguilar; Magali Espinosa Castilla; Jorge Meléndez Zajgla; Noemí Meraz-Cruz; Claudia Huesca-Gómez; Ricardo Gamboa-Ávila; Erika Olivia Gómez-González
Journal:  Cancer Biol Ther       Date:  2016-06-03       Impact factor: 4.742

2.  Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma.

Authors:  J-Y Chuang; W-L Lo; C-Y Ko; S-Y Chou; R-M Chen; K-Y Chang; J-J Hung; W-C Su; W-C Chang; T-I Hsu
Journal:  Oncogenesis       Date:  2017-05-22       Impact factor: 7.485

3.  Dehydroepiandrosterone modulates oxidative DNA damage in pancreatic cancer: A case-control study.

Authors:  Hamid Reza Fazli; Ashraf Mohamadkhani; Hamed Reza Godarzi; Akram Pourshams; Mojtaba Jafari Nia
Journal:  JGH Open       Date:  2021-06-26

Review 4.  Steroidomics for the Prevention, Assessment, and Management of Cancers: A Systematic Review and Functional Analysis.

Authors:  Nguyen Hoang Anh; Nguyen Phuoc Long; Sun Jo Kim; Jung Eun Min; Sang Jun Yoon; Hyung Min Kim; Eugine Yang; Eun Sook Hwang; Jeong Hill Park; Soon-Sun Hong; Sung Won Kwon
Journal:  Metabolites       Date:  2019-09-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.